慢性乙型肝炎患者肝组织Toll样受体2、3的表达水平及临床意义

杨景毅; 程书权; 曹亚昭; 黄成军; 蒋福明

doi:10.3969/j.issn.1001-5256.2018.02.012

慢性乙型肝炎患者肝组织Toll样受体2、3的表达水平及临床意义

DOI: 10.3969/j.issn.1001-5256.2018.02.012

1. 桂林市第三人民医院肝病科
2. 桂林医学院研究生学院

基金项目:

桂林市科技局立项课题(2011019-6)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 1938
- HTML全文浏览量: 50
- PDF下载量: 439
- 被引次数: 0
出版历程
- 出版日期: 2018-02-20

Expression of Toll-like receptors 2 and 3 in liver tissue and its clinical significance in patients with chronic hepatitis B

Department of Hepatology, The Third People′s Hospital of Guilin

Research funding:

摘要

摘要:
目的研究慢性乙型肝炎（CHB）患者肝组织Toll样受体（TLR）2、3的表达变化与肝脏炎症活动度、肝纤维化程度的相关性及其临床意义。方法收集桂林市第三人民医院肝病科自2013年1月-2016年12月住院且初次诊断为CHB的患者104例,运用1秒钟快速肝穿刺活组织检查方法获取CHB患者的肝组织,分别进行TLR2、TLR3免疫组化染色,10例肝血管瘤者趋于正常的瘤旁肝组织作为对照组。比较两组TLR2、TLR3与肝脏炎症活动度、肝纤维化程度的相关性。等级资料多组间比较采用KruskalWallis H检验,相关性分析采用Spearman相关分析。结果对照组未见明显的TLR2、TLR3阳性表达;TLR2在CHB患者肝组织中表达较弱,TLR2表达强度与肝组织炎症活动度分级、肝纤维化程度分级无相关性（rs值分别为-0.086和-0.112,P值均>0.05）;TLR3在CHB患者肝组织中表达较强,TLR3的表达强度与肝组织炎症活动度分级呈显著的正相关性（rs=0.528,P<0.01）,亦与肝组织纤维化分级呈显著的正相关性（rs=0.510,P<0.01）。结论 TLR3可能参与...
- 肝炎,乙型,慢性 /
- Toll样受体2 /
- Toll样受体3 /
- 病理过程
Abstract:
Objective To investigate the correlation of the expression of Toll-like receptor 2 (TLR2) and Toll-like receptor 3 (TLR3) in live tissue with the grade of liver inflammation and degree of liver fibrosis and related clinical significance in patients with chronic hepatitis B (CHB) .Methods A total of 104 patients who were hospitalized in Department of Hepatology, The Third People' s Hospital of Guilin, from January 2013 to December 2016 and were diagnosed with CHB were enrolled.Liver biopsy was used to obtain liver tissue samples from CHB patients, and immunohistochemical staining of TLR2 and TLR3 was performed.Normal adjacent liver tissue samples collected from 10 patients with hepatic hemangioma were used as controls.The correlation of TLR2 and TLR3 with the grade of liver inflammation and degree of liver fibrosis was analyzed.The Kruskal-Wallis H test was used for comparison between multiple groups, Spearman correlation analysis was used to investigate correlation.Results There was no marked positive expression of TLR2 and TLR3 in the control group.There was weak expression of TLR2 in the liver tissue of CHB patients, and the expression of TLR21 was not correlated with the grade of liver inflammation or the degree of liver fibrosis (rs=-0.086 and-0.112, both P > 0.05) .There was strong expression of TLR3 in the liver tissue of CHB patients, and the expression of TLR3 was significantly positively correlated with the grade of liver inflammation (rs= 0.528, P <0.01) ; TLR3 also had a linear relationship with the grade of liver inflammation (χ2= 16.679, P < 0.01) .Conclusion TLR3 may be involved in the immune pathogenesis of CHB and the pathological process of liver fibrosis.
- hepatitis B, chronic /
- Toll-like receptor 2 /
- Toll-like receptor 3 /
- pathologic processes

HTML全文

参考文献(25)

[1]GAO Z, ZHANG LL.Toll like receptors mediated innate immune responses against HBV infection[J].J Clin Hepatol, 2011, 27 (6) :667-669. (in Chinese) 高珍, 张伦理.Toll样受体介导的抗乙型肝炎病毒的固有免疫[J].临床肝胆病杂志, 2011, 27 (6) :667-669.

[2]HASHIMOTO C, HUDSON KL, ANDERSON KV.The Toll gene of Drosophila, requiredfor dorsal-ventral embryonic polarity, appears to eneode a transmembrane protein[J].Cell, 1988, 52 (2) :269-279.

[3]YI D, CHENG SQ.Expression and role of Toll-like receptor in chronic hepatitis B[J].Hua Xia Med, 2015, 28 (5) :171-174. (in Chinese) 易丹, 程书权.Toll样受体在慢性乙型肝炎中的表达及作用[J].华夏医学, 2015, 28 (5) :171-174.

[4]AIT-GOUGHOULTE M, LUCIFORA J, ZOULIM F, et al.Innate antiviral immune responses to hepatitis B virus[J].Viruses, 2010, 2 (7) :1394-1410.

[5]LOPES JA, BORGES-CANHA M, PIMENTEL-NUNES P.Innate immunity and hepatocarcinoma:can Toll-like receptors open the door to oncogenesis[J].World J Hepatol, 2016, 8 (3) :162-182.

[6]KIZILTAS S.Toll-like receptors in pathophysiology of liver diseases[J].World J Hepatol, 2016, 8 (32) :1354-1369.

[7]ZHANG RR, YANG XF, DONG J, et al.Toll-like receptor 2 drives Th17 cell activation in inflammatory response to hepatitis B virus infection[J].J Clin Hepatol, 2014, 30 (9) :877-881. (in Chinese) 赵荣荣, 杨晓飞, 董杰, 等.Toll样受体2介导的Th17细胞活化在HBV感染中的作用[J].临床肝胆病杂志, 2014, 30 (9) :877-881.

[8] JIANG FM, CHENG SQ.Expression of Toll-like receptors 3 and 4and its clinical significance in patients with chronic hepatitis B[J].Int J Virol, 2017, 24 (3) :209-212. (in Chinese) 蒋福明, 程书权.慢性乙型肝炎患者Toll样受体3、4的表达及其临床意义[J].国际病毒学杂志, 2017, 24 (3) :209-212.

[9]LI HJ, ZHAI NC, SONG HX, et al.The role of immune cells in chronic HBV infection[J].J Clin Transl Hepatol, 2015, 3 (4) :277-283.

[10]ZHANG X, MA Z, LIU H, et al.Role of Toll-like receptor 2 in the immune response against headnaviral infection[J].J Hepatol, 2012, 57 (3) :522-528.

[11]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :I-XVI. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.

[12]Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.

[13]ZOU ZQ, WANG L, WANG K, et al.Innate immune targets of hepatitis B virus infection[J].World J Hepatol, 2016, 8 (17) :716-725.

[14]YANG SY, LI H, LI X, et al.Role of TOLL-like receptor signal transduction pathway in inflammatory reaction induced by endoplasmic reticulum stress[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2017, 11 (3) :222-227. (in Chinese) 杨思园, 李辉, 李鑫, 等.TOLL样受体信号转导通路在内质网应激致炎症反应中的作用[J/CD].中华实验和临床感染病杂志:电子版, 2017, 11 (3) :222-227.

[15]PEI RJ, CHEN XW, LU MJ.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways[J].World J Gastroenterol, 2014, 20 (33) :11618-11629.

[16]MAI CW, KANG YB, PICHIKA MR.Should a Toll-like receptor4 (TLR-4) agonist or antagonist be designed to treat cancer?TLR-4:its expression and effects in the ten most common cancers[J].Onco Targets Ther, 2013, 5 (6) :1573-1587.

[17]KARIMI-GOOGHERI M, ARABABADI MK.TLR3 plays significant roles against hepatitis B virus[J].Mol Biol Rep, 2014, 41 (5) :3279-3286.

[18]HUANG ZX.Toll receptor 2, 7, expression and function in chronic hepatitis B virus infection and antiviral therapy[D].Guangzhou:Southern Medical Science, 2011. (in Chinese) 黄祖雄.Toll样受体2、7在慢性乙型肝炎病毒感染及抗病毒治疗中的表达和功能研究[D].广州:南方医科大学, 2011.

[19]CHEN Y, SHI HB, ZHANG F, et al.Expression of TLR2, TLR4 and TLR9 in patients with chronic severe hepatitis and rats with liver failure[J].World Chin J Dig, 2010, 18 (13) :1320-1325. (in Chinese) 陈煜, 时红波, 张帆, 等.TLR2、TLR4和TLR9在慢性重型肝炎患者及肝衰竭大鼠中的表达[J].世界华人消化杂志, 2010, 18 (13) :1320-1325.

[20]CHEN L, XU YY, ZHOU JM, et al.TLR3 dsRNA agonist inhibits growth and invasion of Hep G2.2.15 HCC cells[J].Oncol Rep, 2012, 28 (1) :200-206.

[21]AYOOBI F, HASSANSHAHI G, ZAINODINI N, et al.Reduced expression of TRIF in chronic HBV infected Iranian patients[J].Clin Res Hepatol Gastroenterol, 2013, 37 (5) :491-495.

[22]Chinese Society of Infectious Diseases, Chinese Medical Association, Expert Committee for Prevention and Management of Liver Inflammation.Inflammation of the liver and its prevention and control expert consensus[J].Chin J Pract Intern Med, 2014, 34 (2) :152-162. (in Chinese) 中华医学会感染病学分会, 肝脏炎症及其防治专家共识专家委员会.肝脏炎症及其防治专家共识[J].中国实用内科杂志, 2014, 34 (2) :152-162.

[23]HUANG YW, LIN SC, WEI SC, et al.Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy[J].Antivir Ther, 2013, 18 (7) :877-884.

[24]YIN JW, PING HUANG M, ZHONG B.Intrahepatic Toll-like receptor 3 in chronic HBV infection subjects:asymptomatic carriers, active chronic hepatitis, cirrhosis, and hepatocellular carcinoma[J].Hepat Mon, 2016, 16 (6) :e34432.

[25]XUE RY, ZHANG DY, WU H, et al.Toll-like receptor 3 gene deficiency aggravates carbon tetrachloride-induced liver fibrosis in mice, 2016, 23 (1) :1-5. (in Chinese) 薛如意, 张丹瑛, 吴昊, 等.Toll样受体3基因缺陷促进四氯化碳诱导的小鼠肝纤维化损伤[J].中国临床医学, 2016, 23 (1) :1-5.

施引文献

资源附件(0)

访问统计